JP2025508406A5 - - Google Patents
Info
- Publication number
- JP2025508406A5 JP2025508406A5 JP2024548386A JP2024548386A JP2025508406A5 JP 2025508406 A5 JP2025508406 A5 JP 2025508406A5 JP 2024548386 A JP2024548386 A JP 2024548386A JP 2024548386 A JP2024548386 A JP 2024548386A JP 2025508406 A5 JP2025508406 A5 JP 2025508406A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310581P | 2022-02-16 | 2022-02-16 | |
| US63/310,581 | 2022-02-16 | ||
| US202263337828P | 2022-05-03 | 2022-05-03 | |
| US63/337,828 | 2022-05-03 | ||
| US202363482200P | 2023-01-30 | 2023-01-30 | |
| US63/482,200 | 2023-01-30 | ||
| PCT/US2023/013098 WO2023158668A1 (en) | 2022-02-16 | 2023-02-15 | Neuroactive steroids for treatment of cns-related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508406A JP2025508406A (ja) | 2025-03-26 |
| JP2025508406A5 true JP2025508406A5 (https=) | 2026-02-25 |
| JPWO2023158668A5 JPWO2023158668A5 (https=) | 2026-02-25 |
Family
ID=85569830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024548386A Pending JP2025508406A (ja) | 2022-02-16 | 2023-02-15 | Ｃｎｓ関連障害を処置するための神経活性ステロイド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250295674A1 (https=) |
| EP (1) | EP4479032A1 (https=) |
| JP (1) | JP2025508406A (https=) |
| KR (1) | KR20240148425A (https=) |
| CN (1) | CN119072304A (https=) |
| AU (1) | AU2023220976A1 (https=) |
| CA (1) | CA3252357A1 (https=) |
| IL (1) | IL315023A (https=) |
| MX (1) | MX2024009974A (https=) |
| TW (1) | TW202341995A (https=) |
| WO (1) | WO2023158668A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015002252A (es) | 2012-08-21 | 2015-07-21 | Sage Therapeutics Inc | Metodos para tratar epilepsia o estado de epilepsia. |
| JP6470258B2 (ja) | 2013-04-17 | 2019-02-13 | セージ セラピューティクス， インコーポレイテッド | １９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法 |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| TWI904593B (zh) | 2016-08-23 | 2025-11-11 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| EP3720867A1 (en) | 2017-12-08 | 2020-10-14 | Sage Therapeutics, Inc. | Deuterated 21 -[4-cyano-pyrazol-1 -yl]-19-nor-pregan-3. alpha-ol-20-one derivatives for treating cns disorders |
| AU2022266680A1 (en) * | 2021-04-29 | 2023-11-02 | Sage Therapeutics, LLC | 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid for use in treating major depressive disorder and postpartum depression |
| CN117442618B (zh) * | 2023-10-23 | 2025-11-14 | 国科大杭州高等研究院 | 化合物ly2940094在制备治疗中枢神经系统脱髓鞘疾病药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6470258B2 (ja) | 2013-04-17 | 2019-02-13 | セージ セラピューティクス， インコーポレイテッド | １９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法 |
| TWI904593B (zh) | 2016-08-23 | 2025-11-11 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| EP3720867A1 (en) | 2017-12-08 | 2020-10-14 | Sage Therapeutics, Inc. | Deuterated 21 -[4-cyano-pyrazol-1 -yl]-19-nor-pregan-3. alpha-ol-20-one derivatives for treating cns disorders |
| CA3103421A1 (en) * | 2018-06-12 | 2019-12-19 | Sage Therapeutics, Inc. | A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof |
| CN111454318A (zh) * | 2019-01-20 | 2020-07-28 | 浙江易众化工有限公司 | 抗抑郁药物sage-217的晶型及其制备方法 |
| US20230285417A1 (en) | 2020-07-20 | 2023-09-14 | Sage Therapeutics, Inc. | Formulations of 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof |
-
2023
- 2023-02-15 EP EP23710570.5A patent/EP4479032A1/en active Pending
- 2023-02-15 KR KR1020247030934A patent/KR20240148425A/ko active Pending
- 2023-02-15 JP JP2024548386A patent/JP2025508406A/ja active Pending
- 2023-02-15 US US18/839,147 patent/US20250295674A1/en active Pending
- 2023-02-15 TW TW112105363A patent/TW202341995A/zh unknown
- 2023-02-15 WO PCT/US2023/013098 patent/WO2023158668A1/en not_active Ceased
- 2023-02-15 MX MX2024009974A patent/MX2024009974A/es unknown
- 2023-02-15 IL IL315023A patent/IL315023A/en unknown
- 2023-02-15 AU AU2023220976A patent/AU2023220976A1/en active Pending
- 2023-02-15 CN CN202380033285.6A patent/CN119072304A/zh active Pending
- 2023-02-15 CA CA3252357A patent/CA3252357A1/en active Pending